When TRT Is Actually A PED (And Most People Don’t Realize It)

Why It Matters

The distinction affects anti-doping policy, competitive fairness, and clinical practice: misapplied TRT can unintentionally enhance performance and trigger TUE scrutiny, so clinicians and athletes must weigh treatment against nonpharmacologic recovery first.

Summary

Speakers argue that testosterone replacement therapy (TRT) can function as a performance-enhancing drug when prescribed without a clear medical indication, especially for competitive athletes. High training loads can suppress endogenous testosterone to low-normal levels, and a standard replacement dose (e.g., 100–150 mg/week) can raise levels to high-normal (600–800 ng/dL), potentially conferring an athletic advantage. They recommend conservative management—rest, adjusted training and calories, and retesting—before initiating TRT or seeking a Therapeutic Use Exemption (TUE). The discussion underscores uncertainty about dose–response effects within the normal range but cautions against reflexive treatment.

Original Description

A standard replacement dose, in a man adaptively suppressed by training load, is not the same intervention as the same dose in a hypogonadal man. The lifter audience needs to hear this. #trt #peds #testosterone #barbellmedicine